Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Gapping up/down: HAS +11%, GOLD +5%, SYY +3% and TSN +2% after earnings, X and FDX +1% after upgrades; NWL -3% and NAT -2% after earnings, IP -1% after downgrade<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>HAS</strong> +10.7%, <strong>DO</strong> +6.1%, <strong>GOLD</strong> +4.6%, <strong>BWP</strong> +3.8%, <strong>SYY</strong> +2.9%, <strong>TI</strong> +2.7%, <strong>TSN</strong> +2.1%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>CERU</strong> +12.3% (likely continued M&A speculation)</li><li><strong>CBR</strong> +6.9% (Allgeier to acquire Ciber's business in Germany and Denmark)</li></ul><p><strong>Select metals/mining stocks trading higher</strong>:</p><ul><li><strong>HMY</strong> +3.4%, <strong>AU</strong> +2.8%, <strong>AG</strong> +2.4%, <strong>MUX</strong> +2%, <strong>KGC</strong> +2%, <strong>IAG</strong> +1.9%, <strong>CLF</strong> +1.8%, <strong>PAAS</strong> +1.6%, <strong>ABX</strong> +1.5%, <strong>GDX</strong> +1.5%, <strong>NEM</strong> +1.3%, <strong>FCX</strong> +1%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>GALE</strong> +83.3% (announces results from a meeting of the DSMB for two trials w/ NeuVax plus trastuzumab)</li><li><strong>SDRL</strong> +4.9% (continuing to rebound following last week's decline)</li><li><strong>SDPI</strong> +2.8% (Lone Star Value Management discloses 11.1% active stake (prior 3.5%); informally suggested a director candidate )</li><li><strong>AMD</strong> +1.9% (Barron's profiles positive view on AMD)</li><li><strong>JD</strong> +1.6% (Wal-Mart (WMT) increases passive stake to 12.1% (prior 10.8%))</li><li><strong>SPWR</strong> +1.1% (awarded a $96,252,862 Defense Logistics Agency contract)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>COG</strong> +6.2% (upgraded to Overweight from Neutral at JP Morgan; upgraded to Positive from Neutral at Susquehanna)</li><li><strong>CRR</strong> +4.4% (upgraded to Buy from Hold at Evercore ISI)</li><li><strong>GLUU</strong> +3.7% (upgraded to Buy from Neutral at ROTH Capital)</li><li><strong>X</strong> +1% (upgraded to Buy from Hold at Argus)</li><li><strong>FDX</strong> +0.7% (upgraded to Outperform from Mkt Perform at Raymond James)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>DRD</strong> -6.7%, <strong>NWL</strong> -3%, <strong>NAT</strong> -2.2%, <strong>ATW</strong> -1.2%, <strong>AINV</strong> -1.2%, <strong>CNA</strong> -0.5%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>DHT</strong> -1% (rejects Frontline's (FRO) proposal)</li></ul><p><strong>Select financial related names showing weakness</strong>:</p><ul><li><strong>SAN</strong> -2.3%, <strong>DB</strong> -1.6%, <strong>RBS</strong> -1.4%, <strong>CS</strong> -1.2%, <strong>BBVA</strong> -1%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>SHIP</strong> -8.3% (entered into equity distribution agreement with Maxim to offer and sell up to $20 million of its common shares)</li><li><strong>PETX</strong> -6.6% (provides business update)</li><li><strong>TIF</strong> -4.4% (CEO steps down, co commences search successor; downgraded to Neutral from Buy at Mizuho)</li><li><strong>MDWD</strong> -4.1% (EMA has endorsed the extension of the Children Innovative Debridement Study population to include patients age one to 18; co will initiate the second stage of the study)</li><li><strong>NXTD</strong> -3.8% (files to withdraw Registration Statement on Form S-3 filed Sept 30, 2016)</li><li><strong>CACC</strong> -2.4% (received CID on Nov 7 from the FTC seeking information on the polices, practices and procedures in allowing car dealers to use GPS Starter Interrupters on consumer vehicles)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>BLUE</strong> -4.5% (downgraded to Neutral from Buy at ROTH Capital)</li><li><strong>VSTO</strong> -1.8% (downgraded to Neutral from Buy at DA Davidson)</li><li><strong>IP</strong> -1.2% (downgraded to Underweight from Equal Weight at Barclays )</li><li><strong>AZN</strong> -0.6% (downgraded to Sell from Hold at Shore Capital)</li><li><strong>AN</strong> -0.5% (downgraded to Hold from Buy at Evercore ISI)</li></ul></td> </tr></table>"